Last update 23 Nov 2024

PM-8003

Overview

Basic Info

Drug Type
Trispecific antibody
Synonyms
PM 8003, PM8003
Target
PDL1 x TGF-β x VEGF
Mechanism
PDL1 inhibitors(Programmed death-ligand 1 inhibitors), TGF-β inhibitors(Transforming growth factor beta inhibitors), VEGF inhibitors(Vascular endothelial growth factor inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Pumis Biotechnology (Zhuhai) Co., Ltd.Pumis Biotechnology (Zhuhai) Co., Ltd.Startup
Active Organization
Pumis Biotechnology (Zhuhai) Co., Ltd.Pumis Biotechnology (Zhuhai) Co., Ltd.Startup
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with PM-8003
CTR20211844 / RecruitingPhase 1/2
评价PM8003注射液在晚期实体肿瘤患者中的耐受性、安全性、药代动力学特征及初步疗效的I期临床试验及在晚期实体瘤中考察初步疗效的IIa期临床试验
[Translation] Phase I clinical trial to evaluate the tolerability, safety, pharmacokinetic characteristics and preliminary efficacy of PM8003 injection in patients with advanced solid tumors and Phase IIa clinical trial to examine the preliminary efficacy in patients with advanced solid tumors
ChiCTR2100049391 / SuspendedPhase 1IIT
Phase I clinical trial to evaluate the tolerability, safety, pharmacokinetic characteristics and primary efficacy of PM8003 injection in patients with advanced solid tumors and Phase IIa clinical trial to evaluate the primary efficacy of PM8003 injection in advanced solid tumors
100 Clinical Results associated with PM-8003
Login to view more data
100 Translational Medicine associated with PM-8003
Login to view more data
100 Patents (Medical) associated with PM-8003
Login to view more data
100 Deals associated with PM-8003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
CN
Pumis Biotechnology (Zhuhai) Co., Ltd.Pumis Biotechnology (Zhuhai) Co., Ltd.Startup
31 Aug 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free